Biotech industry to gather at BIO International Convention in San Diego

June 3, 2022

More than 11,000 attendees from around the globe will be in San Diego, June 13-16, for the 2022 Biotechnology Innovation Organization (BIO) International Convention. After two years as a virtual conference due to the COVID-19 pandemic, for the first time in three years the in-person event is back and is being promoted as the world’s largest gathering of the biotechnology industry., which will be providing onsite coverage of the convention in San Diego, spoke with Rich Masters, chief public affairs and marketing officer for BIO, about the networking, partnering, and education opportunities at this year's convention.

"The reason conventions can happen in person again is because of our companies. This is like an amazing victory lap for science in the U.S.," Masters said. "It's going to be one of the largest gatherings of investors and science, with BIO [serving] as a matchmaker between these partners."

San Diego is a hub for biotech research and innovation, and the BIO International Convention will feature more than 100 interactive sessions across four days covering a variety of therapeutic areas. Seven-time Grand Slam tennis singles champion Venus Williams is the keynote and will discuss her experience as a patient advocate, having been diagnosed with the autoimmune disorder Sjögren's syndrome.

Masters highlighted the fact that BIO is not only the world's largest biotechnology trade association but is also the largest advocacy group representing over 1,000 member companies, state biotech organizations, as well as academic and research institutions, advocating for public policies that represent the best interests of its membership.

"We are an advocacy organization based in Washington, DC, and we work with chapters all over the U.S.," said Masters, who called BIO a powerful lobby working to "make sure public policy does not get in the way" of scientific breakthroughs.

Visit the convention website and watch the video below to learn more.

What is the investment community excited about in 2022?
Breaking down the sector based on types of investment, 2022 is shaping up to be an exciting year for biotech investors, according to Gabriel Cavazos,...
Why did biotech valuations boom in 2021, and what does it mean for 2022?
Dennis Purcell, founder Aisling Capital and one of the founders of the J.P. Morgan Healthcare Conference, shared his expert opinions on the state of the...
Despite volatility in biotech markets, investors remain enthusiastic
While the biotech markets are down to start 2022, there is an optimistic view among biotech investors, according to Camille Samuels, partner at Venrock,...
Resilience key to success during pandemic and beyond
It has been a challenging past couple of years for the world with the pandemic impacting seemingly every aspect of life. Companies that have remained...
How biotech startups can secure funding, according to investors
What are strategies that emerging biotech companies can use to attract investors and secure funding that supports the development of their programs and...

Copyright © 2022

Last Updated 7/20/2022 2:29:55 PM